May 24, 2024
Experts have long cautioned against eating late at night, especially a large meal loaded with fats or sugars. Now there’s another reason to listen to their […]
May 24, 2024
BERLIN — New data from the SOFT and TEXT trials showed that women with premenopausal invasive lobular carcinoma, than those with invasive ductal carcinoma, experience a […]
May 23, 2024
TOPLINE: Vaginal estrogen therapy does not increase the risk for recurrence in women with hormone receptor(HR)-negative breast cancer or in those with HR-positive tumors concurrently treated […]
May 22, 2024
Breast cancer mortality was significantly lower among patients who used statins than in those who did not use these cholesterol-lowering drugs, a new study finds. Previous […]
May 22, 2024
TOPLINE: A structured exercise program leads to improvements in sexual health and sexual symptoms caused by endocrine therapy, as well as fatigue and overall quality of […]
May 22, 2024
TOPLINE: For patients with early-stage cervical cancer without any high-risk factors, postoperative radiotherapy (RT) alone yields similar outcomes as concurrent chemoradiotherapy, regardless of histological subtype, but […]
May 21, 2024
In February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a new regimen for first-line metastatic pancreatic adenocarcinoma called NALIRIFOX. The […]
May 21, 2024
For breast cancer survivors harboring BRCA1/2 gene mutations, the prospect of future pregnancy often raises concerns because of limited data on the safety of assisted reproductive […]
May 21, 2024
The US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of […]